Literature DB >> 35241560

Safety of Insertion of Percutaneous Totally Implantable Central Venous Access Devices by Surgical Residents.

Keisuke Obuchi1, Ken Imaizumi2, Hiroyuki Kasajima1, Michihiro Kurushima1, Minoru Umehara1, Yousuke Tsuruga1, Daisuke Yamana1, Kentaro Sato1, Aya Sato1, Shinsaku Suzuki3, Kazuaki Nakanishi1.   

Abstract

BACKGROUND/AIM: To compare the outcomes of totally implantable central venous access device (TIVAD) insertions by surgical residents (SRs) with those by experienced surgeons (ESs) and establish the safety of percutaneous TIVAD insertion by SRs. PATIENTS AND METHODS: A total of 700 insertions were successfully performed between January 2015 and December 2019 in our Department. The puncture site conversion and complication rates were compared, and risk factors related to complications were analysed.
RESULTS: In total, 84 and 616 insertions were performed in the SR and ES groups, respectively. SRs mainly punctured the internal jugular vein (IJV), and ESs punctured the subclavian vein (SV). The conversion rate from the IJV to SV was similar, whereas that from the SV to IJV was higher by SRs than ESs. Overall, early, and delayed complications were similar between the two groups.
CONCLUSION: Percutaneous TIVAD inserted into the IJV by an SR was demonstrated to be safe.
Copyright © 2022, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.

Entities:  

Keywords:  Percutaneous approach; infection; surgical education; totally implantable central venous access devices; ultrasonography

Mesh:

Year:  2022        PMID: 35241560      PMCID: PMC8931890          DOI: 10.21873/invivo.12791

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  37 in total

1.  Evaluation of totally implantable central venous access devices with the cephalic vein cut-down approach: Usefulness of preoperative ultrasonography.

Authors:  Ryota Otsubo; Toshiko Hatachi; Kenichiro Shibata; Takuya Yoshida; Hironosuke Watanabe; Masahiro Oikawa; Megumi Matsumoto; Hiroshi Yano; Hideki Taniguchi; Takeshi Nagayasu
Journal:  J Surg Oncol       Date:  2015-12-08       Impact factor: 3.454

2.  Radiologic placement of subcutaneous infusion chest ports for long-term central venous access.

Authors:  B Funaki; G X Szymski; C A Hackworth; J D Rosenblum; R Burke; T Chang; J A Leef
Journal:  AJR Am J Roentgenol       Date:  1997-11       Impact factor: 3.959

3.  The role of antibiotic prophylaxis in totally implantable venous access device placement: results of a single-center prospective randomized trial.

Authors:  Hasan Karanlik; Sidika Kurul; Pinar Saip; Ersin Selcuk Unal; Fatma Sen; Rian Disci; Erkan Topuz
Journal:  Am J Surg       Date:  2011-05-23       Impact factor: 2.565

4.  Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.

Authors:  R Biffi; F de Braud; F Orsi; S Pozzi; S Mauri; A Goldhirsch; F Nolè; B Andreoni
Journal:  Ann Oncol       Date:  1998-07       Impact factor: 32.976

5.  Subcutaneously implanted central venous access devices in cancer patients: a prospective analysis.

Authors:  R E Schwarz; J S Groeger; D G Coit
Journal:  Cancer       Date:  1997-04-15       Impact factor: 6.860

6.  Clinical impact of peripherally inserted central catheters vs implanted port catheters in patients with cancer: an open-label, randomised, two-centre trial.

Authors:  Knut Taxbro; Fredrik Hammarskjöld; Bo Thelin; Freddi Lewin; Helga Hagman; Håkan Hanberger; Sören Berg
Journal:  Br J Anaesth       Date:  2019-04-17       Impact factor: 9.166

7.  Analysis of risk factors for central venous port failure in cancer patients.

Authors:  Ching-Chuan Hsieh; Hsu-Huei Weng; Wen-Shih Huang; Wen-Ke Wang; Chiung-Lun Kao; Ming-Shian Lu; Chia-Siu Wang
Journal:  World J Gastroenterol       Date:  2009-10-07       Impact factor: 5.742

8.  A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.

Authors:  C Araújo; J P Silva; P Antunes; J M Fernandes; C Dias; H Pereira; T Dias; J L Fougo
Journal:  Eur J Surg Oncol       Date:  2007-06-12       Impact factor: 4.424

9.  Totally implantable subcutaneous port system versus central venous catheter placed before induction chemotherapy in patients with acute leukaemia-a randomized study.

Authors:  Eva Johansson; Magnus Björkholm; Hjördis Björvell; Robert Hast; Rabbe Takolander; Per Olofsson; Lars Backman; Eddie Weitzberg; Per Engervall
Journal:  Support Care Cancer       Date:  2003-11-25       Impact factor: 3.603

10.  Comparison between Arm Port and Chest Port for Optimal Vascular Access Port in Patients with Breast Cancer: A Systematic Review and Meta-Analysis.

Authors:  Ye Liu; Li-Li Li; Lei Xu; Dong-Dong Feng; Yu Cao; Xiao-Yun Mao; Jin Zheng; Feng Jin; Bo Chen
Journal:  Biomed Res Int       Date:  2020-02-13       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.